• E-mail :[email]
  • Phone : +33472728793
  • Location : Lyon, France
Last update 2018-01-25 09:36:59.064

renaud mahieux PhD biochemistry

Course and current status


2007-: Habilitation à diriger les recherches en Science (HDR), University of Paris 7.

1997: Ph.D. (Microbiology-Molecular virology) University of Paris 6.


Research and management

2013-2017: Head biology dpt, Ecole Normale Supérieure de Lyon.

2012-: board of directors, CIRI U1111

2012-: In charge of Biology at CNAM Rhône Alpes

2009-: team leader INSERM U758 (currently U1111)

2008-: Professor (2ème then 1ere classe) Ecole Normale Supérieure de Lyon.

2006-2010: Adjunct Associate Professor of Biochemistry and Molecular Biology, George Washington University, Washington DC, USA.

2001-2008: INSERM Research associate (CR2 then CR1), Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes URA3015, Institut Pasteur, Paris.

2000-2001: post-doctoral fellow, unité d'oncologie virale, Institut Pasteur, Paris.

1997-2000: post-doctoral fellow, National Cancer Institute, NIH, USA



Expertise, consultancy

- ANR microbiology panel (2013-)

- FNRS (Belgium, 2010-)

- INSERM CSS5 (2007-2012)

- ANRS CSS2 (2007-2012)

Editorial board

- Retrovirology, Journal of Virology, PlosOne



- Sézary prize (French academy of medicine)

Scientific summary

Our main objectives are to understand the physiopathology of the Human T cell Leukemia Virus Type 1 (HTLV-1) infection and to develop new regimen that could either prevent the occurence of Adult T cell Leukemia or that would allow patients treatmentTo achieve this goal, we  take advantage of our combined expertise, of several in vitro or in vivo  models that are available in the team. We also benefit from ongoing collaborations with epidemiologists, biochemists, and chemists.

Main organisms with whom the team collaborates : INSERM, Pasteur Institute, Necker Hospital, CNRS, NIH, George Mason university

Image d’exemple